You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IFN-g

Showing 1 - 25 of 4,658
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Prostatitis Trial (Interferon gamma human recombinant (IFN-G))

Completed
  • Chronic Prostatitis
  • Interferon gamma human recombinant (IFN-G)
  • (no location specified)
May 12, 2022

Humoral and Cellular Immunity in First-cycle SARS-CoV-2

Completed
  • SARS CoV 2 Infection
  • COVID-19
  • LIAISON SARS-CoV-2 TrimericS IgG (DiaSorin)
  • +2 more
  • Catanzaro, Italy
    AOU Mater Domini
Jul 15, 2022

Ingaron in Volunteers for the Prevention of COVID-19

Completed
  • COVID-19 Respiratory Infection
  • Interferon gamma human recombinant (IFN-G)
  • Moscow, Russian Federation
    City Clinical Hospital named after M.E. Zhadkevich Moscow City H
May 20, 2022

COVID-19 Respiratory Infection, Acute Respiratory Disease Trial in Moscow (Interferon gamma human recombinant (IFN-G))

Completed
  • COVID-19 Respiratory Infection
  • Acute Respiratory Disease
  • Interferon gamma human recombinant (IFN-G)
  • Moscow, Russian Federation
    City Clinical Hospital named after M.E. Zhadkevich Moscow City H
Sep 23, 2021

Human Papillomavirus Infection, Anogenital Warts Trial in Moscow (Interferon gamma human recombinant (IFN-G))

Completed
  • Human Papillomavirus Infection
  • Anogenital Warts
  • Interferon gamma human recombinant (IFN-G)
  • Moscow, Russian Federation
    State scientific center of a dermatovenereology and cosmetology
Nov 30, 2021

Friedreich Ataxia Trial in Philadelphia (Interferon Gamma-1b)

Completed
Has Results
  • Friedreich Ataxia
  • Interferon Gamma-1b
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Mar 23, 2021

Metastatic Myxoid Liposarcoma, Metastatic Round Cell Liposarcoma, Metastatic Synovial Sarcoma Trial in United States (Interferon

Active, not recruiting
Has Results
  • Metastatic Myxoid Liposarcoma
  • +15 more
  • Interferon Gamma-1b
  • +2 more
  • Palo Alto, California
  • +6 more
Aug 2, 2022

Chronic Hepatitis C Trial (Danoprevir, Ritonavir, peginterferon alfa-2a)

Completed
Has Results
  • Chronic Hepatitis C
  • (no location specified)
Feb 28, 2021

Triple -Negative Breast Cancer, Estrogen Receptor Negative, HER2/Neu Negative Trial in Buffalo (procedure, drug, biological)

Active, not recruiting
  • Triple -Negative Breast Cancer
  • +4 more
  • Biopsy
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Aug 1, 2022

Malignant Pleural Mesothelioma Trial in Worldwide (rAd-IFN, Celecoxib Oral Product, Gemcitabine)

Active, not recruiting
  • Malignant Pleural Mesothelioma
  • rAd-IFN
  • +2 more
  • Los Angeles, California
  • +41 more
Oct 25, 2021

Leukemia Trial in Philadelphia (Interferon alpha-2B (IFN-a) 3 million units (MU) subcutaneous daily)

Completed
  • Leukemia
  • Interferon alpha-2B (IFN-α) 3 million units (MU) subcutaneous daily
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 20, 2020

HIV Trial in Seattle (Tumor Necrosis Factor, Interferon gamma-1b)

Completed
  • HIV Infections
  • Tumor Necrosis Factor
  • Interferon gamma-1b
  • Seattle, Washington
    Univ of Washington
Oct 28, 2021

MDS, Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial in Pittsburgh (IFN-? (interferon gamma-1b) injection)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • IFN-γ (interferon gamma-1b) injection
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jan 5, 2023

HIV Trial in New York (Zidovudine, Interferon gamma-1b)

Completed
  • HIV Infections
  • New York, New York
    Cornell University A2201
Oct 28, 2021

Stage III Malignant Melanoma of Skin AJCC V6, Stage IV Malignant Melanoma of Skin Trial in Santiago (TAPCells vaccine)

Completed
  • Stage III Malignant Melanoma of Skin AJCC V6
  • Stage IV Malignant Melanoma of Skin
  • TAPCells vaccine
  • Santiago, RM, Chile
    Faculty of Medicine, University of Chile
Nov 21, 2023

Hepatitis Delta Virus Trial in Worldwide (Lonafarnib, Ritonavir, PEG IFN-alfa-2a)

Recruiting
  • Hepatitis Delta Virus
  • Fresno, California
  • +117 more
Sep 30, 2021

Action of Interferon in Treatment of Myeloproliferative

Recruiting
  • Myeloproliferative Neoplasm
    • Villejuif, Ile De France, France
      Inserm U1287
    Apr 28, 2023

    Microvesicles and Monocytes to Predict Mortality of Cirrhosis

    Active, not recruiting
    • Cirrhosis
      • Bobigny, France
      • +4 more
      Jan 19, 2023

      Cerebral Arterio-venous Malformation Trial in Limoges (Blood sample)

      Recruiting
      • Cerebral Arterio-venous Malformation
      • Blood sample
      • Limoges, France
        Limoges University Hospital
      Dec 23, 2022

      Head Neck Cancer, Melanoma, Breast Cancer Trial in Shanghai (Recombinant L-IFN adenovirus injection)

      Recruiting
      • Head and Neck Cancer
      • +6 more
      • Recombinant L-IFN adenovirus injection
      • Shanghai, Shanghai, China
        Shanghai Fengxian District Central Hospital
      Jan 16, 2022

      IBD, Dietary Exposure Trial in Groningen (Chicory Fiber)

      Not yet recruiting
      • Inflammatory Bowel Diseases
      • Dietary Exposure
      • Chicory Fiber
      • Groningen, Netherlands
        University Medical Center Groningen
      Aug 25, 2023

      HIV, Hepatitis C Trial in United States (Ribavirin, Interferon alfa-2a, Peginterferon alfa-2a)

      Completed
      • HIV Infections
      • Hepatitis C
      • San Diego, California
      • +23 more
      Oct 28, 2021

      Hemophagocytic Lymphohistiocytoses, Cytokine Storm Trial in Hangzhou (Dexamethasone, Etoposide, Ruxolitinib)

      Not yet recruiting
      • Hemophagocytic Lymphohistiocytoses
      • Cytokine Storm
      • Hangzhou, Zhejiang, China
        The Children's Hospital of Zhejiang University School of Medicin
      Aug 4, 2022

      Tuberculosis Trial in Shanghai (Placebo, Low dose adjuvant, High dose adjuvant)

      Completed
      • Tuberculosis
      • Placebo
      • +4 more
      • Shanghai, Shanghai, China
        Shanghai Public Health clinical Center
      Mar 9, 2022

      Systemic Lupus Erythematosus, Interferon Deficiency Trial in Copenhagen (High Intensity Interval Training)

      Recruiting
      • Systemic Lupus Erythematosus
      • Interferon Deficiency
      • High Intensity Interval Training
      • Copenhagen, Denmark
        Center for Physical Activity Research
      Jul 26, 2022